//
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association
Cholesterol-Lowering Agents
Genotype-Guided Strategy for Oral P2Y12 Inhibitors
Management of No-Reflow Phenomenon in the Catheterization Laboratory
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial
Advances in Coronary No-Reflow Phenomenon-a Contemporary Review
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents